Abstract
During the COVID-19 pandemic, Florida reported some of the highest cases and deaths in the US. County-level variation in COVID-19 outcomes has yet to be comprehensively investigated. Here, we assess corelates of COVID-19 outcomes among Florida counties that explain variation in case, mortality, and case fatality rates (CFR) across pandemic waves. County-level administrative data and COVID-19 case reports was obtained from public repositories. We tested spatial autocorrelation to assess geographic clustering of case rate, mortality rate, and CFR. Stepwise linear regression was employed to investigate the association between COVID-19 outcomes and 18 demographic, socioeconomic, and health-related county-level predictors. We found mortality rate and CFR were significantly higher in rural counties compared to urban counties, among which significant differences in vaccination coverage were also observed. Multivariate analysis found that the percentage of the population aged over 65 years, the percentage of obese people, and the percentage of the rural population were significant predictors of COVID-19 case rate. Median age, vaccination coverage, percentage of people who smoke, and percentage of the population with diabetes were significant influencing factors for CFR. Importantly, higher vaccination coverage was significantly associated with a reduction in case rate (R = -0.26, p = 0.03) and mortality (R = -0.51, p < 0.001). Last, we found that spatial dependencies play a role in explaining variations in COVID-19 CFR among Florida counties. Our findings emphasize the need for targeted, equitable public health strategies to reduce disparities and enhance population resilience during public health crises.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The abstract has been revised to make it more concise. The introduction has been revised to remove the repetitive information. Figure 1 is updated, as Figure 1D was missing in the text. Figure 6 has been revised to include the all-cause mortality rate during pre-pandemic and pandemic times. The results, discussion, and conclusion have been revised to increase readability.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
